Entrepreneur Jesse Itzler's journey to selling Zico Coconut Water to Coca-Cola involved more than just a business plan. A pivotal moment came when he leveraged a casual connection with actor Matt Damon into a viral stunt that captured the beverage giant's imagination and ultimately closed the deal.
As income investors look toward 2026, a stark choice emerges between Energy Transfer's tempting 7.1% yield and Enterprise Products Partners' quarter-century record of reliable payouts. We examine the risk-reward calculus behind the numbers.
The affordable cosmetics giant e.l.f. Beauty is poised to release its fourth-quarter financial results this week, following a period of robust stock performance and mixed signals from the broader consumer staples sector.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
As T. Rowe Price Group prepares to release its fourth-quarter results, investors are weighing steady revenue growth expectations against a history of occasional misses and a mixed landscape for custody banks.
All eyes are on Stanley Black & Decker (SWK) as it prepares to release its quarterly earnings. Investors are looking for signs of a sustained turnaround amid a mixed industrial machinery landscape.
U-Haul International prepares to report its fourth-quarter financial results amid a mixed landscape for transportation and logistics firms. Investors are watching for signs of a rebound after recent profit misses.
The adhesive and materials giant is expected to post modest revenue growth as investors gauge its resilience against a backdrop of uneven results from packaging industry peers.
As the RBA's policy decisions loom, investors are scouring the market for resilient opportunities. We spotlight three ASX-listed penny stocks—Aura Energy, Beam Communications, and Count Limited—each with a market cap over A$10 million, offering a blend of high-risk potential and strategic positioning in their respective sectors.
Bunge Global SA (NYSE:BG) is set to release its quarterly earnings Wednesday morning, with investors keen to see if the agribusiness leader can sustain its momentum amid shifting commodity markets and analyst skepticism.
Central Garden & Pet (CENT) is scheduled to release its fourth-quarter financial results after Wednesday's market close, with Wall Street anticipating a year-over-year revenue decline. The report comes as the broader household products sector shows investor optimism.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
The Timken Company (NYSE: TKR) is scheduled to release its fourth-quarter financial results before the market opens on Wednesday. Investors will be watching to see if the bearings and power transmission specialist can continue its track record of surpassing Wall Street's forecasts amidst a mixed landscape for industrial machinery firms.
Reynolds Consumer Products (NASDAQ: REYN) is scheduled to release its fourth-quarter financial results before market open on Wednesday. Investors will be watching closely to see if the household goods maker can maintain its track record of outperforming expectations, even as analysts project a slight year-over-year revenue dip.
Western wear retailer Boot Barn (NYSE: BOOT) is scheduled to release its fourth-quarter financial results after market close this Wednesday, with investors keenly watching for signs of sustained growth in a competitive apparel landscape.
Despite stellar fundamentals and a dominant market position, Mastercard's premium valuation is prompting a debate among investors. While bulls champion its profitability and growth, skeptics warn of overextension, suggesting a pullback may offer a more attractive entry point.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
